257 related articles for article (PubMed ID: 37373213)
1. RNA Biomarkers in Bipolar Disorder and Response to Mood Stabilizers.
Pisanu C; Squassina A
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373213
[TBL] [Abstract][Full Text] [Related]
2. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
Rybakowski JK
CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
[TBL] [Abstract][Full Text] [Related]
3. Lithium Pharmacogenetics: Where Do We Stand?
Pisanu C; Melis C; Squassina A
Drug Dev Res; 2016 Nov; 77(7):368-373. PubMed ID: 27633500
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs, Stem Cells in Bipolar Disorder, and Lithium Therapeutic Approach.
Coradduzza D; Garroni G; Congiargiu A; Balzano F; Cruciani S; Sedda S; Nivoli A; Maioli M
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142403
[TBL] [Abstract][Full Text] [Related]
5. Can the response to mood stabilizers be predicted in bipolar disorder?
Geoffroy PA; Bellivier F; Leboyer M; Etain B
Front Biosci (Elite Ed); 2014 Jan; 6(1):120-38. PubMed ID: 24389147
[TBL] [Abstract][Full Text] [Related]
6. Sexual Dysfunction and Mood Stabilizers in Long-Term Stable Patients With Bipolar Disorder.
García-Blanco A; García-Portilla MP; Fuente-Tomás L; Batalla M; Sánchez-Autet M; Arranz B; Safont G; Arqués S; Livianos L; Sierra P
J Sex Med; 2020 May; 17(5):930-940. PubMed ID: 32139195
[TBL] [Abstract][Full Text] [Related]
7. Mood-Stabilizing Antiepileptic Treatment Response in Bipolar Disorder: A Genome-Wide Association Study.
Ho AM; Coombes BJ; Nguyen TTL; Liu D; McElroy SL; Singh B; Nassan M; Colby CL; Larrabee BR; Weinshilboum RM; Frye MA; Biernacka JM
Clin Pharmacol Ther; 2020 Dec; 108(6):1233-1242. PubMed ID: 32627186
[TBL] [Abstract][Full Text] [Related]
8. The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.
Pisanu C; Heilbronner U; Squassina A
Mol Diagn Ther; 2018 Aug; 22(4):409-420. PubMed ID: 29790107
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].
Geoffroy PA; Bellivier F; Henry C
Encephale; 2014 Sep; 40(4):330-7. PubMed ID: 24513018
[TBL] [Abstract][Full Text] [Related]
10. Genetics and antiepileptic mood stabilizer treatment response in bipolar disorder: what do we know?
Ho AM; Weinshilboum RM; Frye MA; Biernacka JM
Pharmacogenomics; 2021 Sep; 22(14):913-925. PubMed ID: 34486896
[TBL] [Abstract][Full Text] [Related]
11. Mood stabilizers for patients with bipolar disorder: the state of the art.
Altamura AC; Lietti L; Dobrea C; Benatti B; Arici C; Dell'Osso B
Expert Rev Neurother; 2011 Jan; 11(1):85-99. PubMed ID: 21158558
[TBL] [Abstract][Full Text] [Related]
12. Childhood maltreatment and clinical response to mood stabilizers in patients with bipolar disorder.
Cascino G; D'Agostino G; Monteleone AM; Marciello F; Caivano V; Monteleone P; Maj M
Hum Psychopharmacol; 2021 Jul; 36(4):e2783. PubMed ID: 33666294
[TBL] [Abstract][Full Text] [Related]
13. [The treatment of mood stabilizers in children and adolescents suffering from bipolar affective disorder].
Green T; Shoval G; Weizman A
Harefuah; 2005 Nov; 144(11):810-5, 821. PubMed ID: 16358659
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.
Smith LA; Cornelius V; Warnock A; Bell A; Young AH
Bipolar Disord; 2007 Jun; 9(4):394-412. PubMed ID: 17547586
[TBL] [Abstract][Full Text] [Related]
15. The rapid suicide protection of mood stabilizers on patients with bipolar disorder: A nationwide observational cohort study in Taiwan.
Tsai CJ; Cheng C; Chou PH; Lin CH; McInnis MG; Chang CL; Lan TH
J Affect Disord; 2016 May; 196():71-7. PubMed ID: 26919054
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review.
Pisanu C; Severino G; De Toma I; Dierssen M; Fusar-Poli P; Gennarelli M; Lio P; Maffioletti E; Maron E; Mehta D; Minelli A; Potier MC; Serretti A; Stacey D; van Westrhenen R; Xicota L; ; Baune BT; Squassina A
Eur Neuropsychopharmacol; 2022 Feb; 55():112-157. PubMed ID: 35016057
[TBL] [Abstract][Full Text] [Related]
17. Impaired glucose metabolism in bipolar patients and response to mood stabilizer treatments.
Steardo L; Fabrazzo M; Sampogna G; Monteleone AM; D'Agostino G; Monteleone P; Maj M
J Affect Disord; 2019 Feb; 245():174-179. PubMed ID: 30391773
[TBL] [Abstract][Full Text] [Related]
18. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
Hamrin V; Pachler M
J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):40-58. PubMed ID: 17284237
[TBL] [Abstract][Full Text] [Related]
19. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
20. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
